Linda Egger earned a BS in biology from Cook College, Rutgers University, an MS in physiology and neurobiology from Rutgers Graduate School, and a PhD in cell and developmental biology from the University of Medicine and Dentistry of New Jersey / Rutgers Graduate School. Prior to joining Merck, Linda worked at BioMetallics Inc. as a biochemist and at Wyeth-Ayerst Research as a pharmacologist. Linda joined Merck Research Laboratories in 1990. Over the next 14 years, Linda carried out basic research in the Immunology and Pharmacology departments, aimed at identifying and validating novel inflammatory targets for a variety of therapeutic areas
Linda joined External Scientific Affairs in 2004 as a Senior Scientist, Scientific Licensing, where she identified and evaluated external research and licensing opportunities in the therapeutic areas of diabetes, obesity, atherosclerosis, and cardiovascular disease. From 2008 through 2011, Linda served as a Franchise Licensing Integrator, Scientific Liaison for the Oncology franchise followed by the Diabetes and Endocrinology franchise. In her current role as Strategic Licensing & Acquisitions Lead, Linda provides scientific leadership for the licensing strategy, search, and evaluation of respiratory and immunology licensing and acquisition opportunities. She works closely with our worldwide licensing scouts to manage the scientific assessment / due diligence and prioritization of potential partnering opportunities, and she collaborates closely with Corporate Licensing by serving as a key member of the deal negotiation team for executing deals. Linda is certified as a Lean Six Sigma Green Belt and as a Certified Licensing Professional (CLP). Linda has authored or co-authored 28 scientific publications. Linda is also a member of several professional organizations including the American Association of Immunologists and the Licensing Executives Society.